Role of Ki67 in breast carcinoma and its association with clinicopathological parameters and luminal subtypes in a tertiary health care center

Authors : Renuka Patil, Krishnara Upadhyaya, Anuradha CK Rao

DOI : 10.18231/j.achr.2019.038

Volume : 4

Issue : 3

Year : 2019

Page No : 199-204

Introduction & Objectives: In clinical practice, the evaluation of the breast tumour proliferative fraction
is of important for the treatment decision, which is commonly performed by the immunohistochemical
staining of a proliferation marker, the Ki67 antigen. The main objective of the current study was to
analyze and evaluate the associations between Ki-67 and common histopathological parameters and luminal
subtypes in the routine clinical setting.
Materials and Methods: A total of seventy cases were enrolled in the study. The surgical specimens were
evaluated and histopathological reporting was done according to College of American Pathologists (CAP)
guidelines. Suitable blocks were selected and immunostaining was performed with ER, PR, Her2/neu and
Ki67 markers. The association between the Ki-67 and histopathological parameters [age, histological type,
nuclear grade, tumor size, multifocality, an in situ component, lymphovascular invasion (LVI), estrogen
and progesterone receptor (ER/PR) expression, human epidermal growth factor receptor (HER-2) status,
axillary involvement and tumor stage] were evaluated in each group. The data thus obtained was analyzed
by SPSS-20 software with chi square test.
Results: The intended age of presentation in the current study was 48.6613.05 years and most common
histological type was invasive ductal carcinoma of no special type (IDC-NST). Tumor size was found to
have an association with Ki67 expression status with significant p value (0.003), were as tumor grade and
pT category did not find any significant association with Ki67 expression. Luminal subtypes and ki67
expression status was seen to have an association with significant p value.
Conclusion: Ki67 was considered as important marker to predict the prognosis for better management of
breast cancer patients.

Keywords: Histopathological parameters, immunohistochemistry, proliferation marker.


Citation Data


Related Articles

Study of histopathological spectrum of diagnosis in lymph node biopsies in a tertiary care centre

Shwetha Pallavi M.S, Manjunatha Y.A

Outcome assessment for pyeloplasty in pediatric age group on the basis of ultrasonography

RK Maurya, RK Tripathi, Ajay Kumar, Pinaki Ranjan Debnath, Vasu Gautam, Arnab Kumar Saha

Maturogenesis: A novel concept based on regeneration for peadatric patients

Kuldeep Singh, Suneel Kumar Gupta, Chanchal Singh, Sakshi Kataria

Exiguobacterium aurantiacum virulent pigment producing a novel pathogenic bacteria associated with cases of corneal ulcers

Deepika Jain, Vilas Kamble

Granulocytic sarcoma presenting as a palpable breast lump in a 13-year-old female as a relapse of AML

Toyaja Jadhav, Ganesh Pendkur, Puneet Baveja

High prevalance of triple negative markers in breast cancer patients in North Maharashtra

Nilesh Jadhav, Nandkumar V Dravid, Arif Kaderi, Dhananjay Newadkar, Arundhati Gadre, Sakshi Agrawal*

Comparative study of dexamethasone nebulisation with magnesium sulphate nebulisation in preventing post operative sore throat following endotracheal intubation

Ashwini H, Seema Kumari K, Lavanya R

Comparing the ease of identifying the subarachnoid space at midline of L3 -L4 interspace by preprocedural ultrasound versus landmark technique - A randomized control study

Bhavani Vaidiyanathan, Sangeeta Dhanger, Joseph Raajesh I

Intranasal midazolam versus intranasal dexmedetomidine as premedication in paediatric patients: A comparative study

Vimal Dangi, Sushil Chand Verma, Vinayak Gour*